US Stock MarketDetailed Quotes

Psyence Biomedical (PBM)

Watchlist
  • 0.7603
  • -0.1105-12.69%
Close Jan 22 15:59 ET
  • 0.7310
  • -0.0293-3.85%
Post 19:43 ET
4.86MMarket Cap-0.36P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Psyence Biomedical (PBM) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Sep 30, 2025
(FY)Mar 31, 2025
(Q2)Sep 30, 2024
(FY)Mar 31, 2024
(Q2)Sep 30, 2023
(FY)Mar 31, 2023
(Q2)Sep 30, 2022
(FY)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
30.18%1.51M
-91.72%3.66M
556.84%1.16M
1,267.39%44.23M
-27.80%176.17K
74.30%3.23M
244K
1.86M
Selling and administrative expenses
28.87%1.15M
84.56%3.32M
382.11%890.48K
10.52%1.8M
-23.72%184.7K
-5.40%1.63M
--242.15K
--1.72M
-Selling and marketing expense
-82.22%48.67K
499.89%483.53K
24,856.06%273.77K
1,046.72%80.6K
--1.1K
-59.86%7.03K
--0
--17.51K
-General and administrative expense
78.18%1.1M
65.06%2.83M
235.88%616.71K
6.02%1.72M
-24.18%183.61K
-4.84%1.62M
--242.15K
--1.7M
Research and development costs
34.57%357.44K
-64.16%342.17K
3,210.74%265.63K
-40.67%954.59K
-561.03%-8.54K
1,072.35%1.61M
--1.85K
--137.24K
Depreciation amortization depletion
30.91%1.33K
1,678.33%4.27K
--1.02K
--240
--0
--0
----
----
-Depreciation and amortization
30.91%1.33K
1,678.33%4.27K
--1.02K
--240
--0
--0
----
----
Other operating expenses
----
----
----
--41.48M
----
----
----
----
Operating profit
-30.18%-1.51M
91.72%-3.66M
-556.84%-1.16M
-1,267.39%-44.23M
27.80%-176.17K
-74.30%-3.23M
-244K
-1.86M
Net non-operating interest income expense
1,985.92%70.06K
270.29%86.52K
86.70%-3.72K
-3,369.43%-50.81K
-3,605.02%-27.94K
1.55K
797.0283
0
Non-operating interest income
--72.82K
4,388.61%95.79K
--0
37.32%2.13K
----
--1.55K
----
--0
Non-operating interest expense
-25.90%2.75K
-82.49%9.27K
-86.70%3.72K
--52.94K
--27.94K
--0
----
----
Total other finance cost
----
----
----
----
----
----
---797.0283
----
Other net income (expense)
-47.56%682.99K
166.74%4.59M
1,333.47%1.3M
-25,645.52%-6.87M
-7,101.52%-105.58K
1,276.42%26.91K
-1.47K
-2.29K
Gain on sale of security
475.84%682.99K
269.97%525.1K
-72.12%-181.73K
-1,247.98%-308.95K
-7,101.52%-105.58K
1,276.42%26.91K
---1.47K
---2.29K
Special income (charges)
----
--0
----
---2.18M
----
--0
----
----
-Less：Restructuring and merger&acquisition
----
--0
----
--2.46M
----
--0
----
----
-Less:Other special charges
----
----
----
---281.5K
----
----
----
----
Other non- operating income (expenses)
----
192.63%4.06M
--1.48M
---4.39M
----
----
----
----
Income before tax
-632.44%-753.25K
101.98%1.01M
145.68%141.47K
-1,495.53%-51.16M
-26.57%-309.68K
-72.55%-3.21M
-244.67K
-1.86M
Income tax
Net income
-632.44%-753.25K
101.98%1.01M
145.68%141.47K
-1,495.53%-51.16M
-26.57%-309.68K
-72.55%-3.21M
-244.67K
-1.86M
Net income continuous Operations
-632.44%-753.25K
101.98%1.01M
145.68%141.47K
-1,495.53%-51.16M
-26.57%-309.68K
-72.55%-3.21M
---244.67K
---1.86M
Minority interest income
Net income attributable to the parent company
-632.44%-753.25K
101.98%1.01M
145.68%141.47K
-1,495.53%-51.16M
-26.57%-309.68K
-72.55%-3.21M
-244.67K
-1.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-632.44%-753.25K
101.98%1.01M
145.68%141.47K
-1,495.53%-51.16M
-26.57%-309.68K
-72.55%-3.21M
-244.67K
-1.86M
Basic earnings per share
-112.53%-0.51
101.83%41.7628
128.02%4.07
-1,418.60%-2.28K
-26.57%-14.5247
-72.55%-150.3871
-11.4754
-87.1552
Diluted earnings per share
-112.53%-0.51
101.83%41.7628
128.02%4.07
-1,418.60%-2.28K
-26.57%-14.5247
-72.55%-150.3871
-11.4754
-87.1552
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(Q2)Sep 30, 2025(FY)Mar 31, 2025(Q2)Sep 30, 2024(FY)Mar 31, 2024(Q2)Sep 30, 2023(FY)Mar 31, 2023(Q2)Sep 30, 2022(FY)Mar 31, 2022
Total revenue 00000000
Operating revenue --0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 30.18%1.51M-91.72%3.66M556.84%1.16M1,267.39%44.23M-27.80%176.17K74.30%3.23M244K1.86M
Selling and administrative expenses 28.87%1.15M84.56%3.32M382.11%890.48K10.52%1.8M-23.72%184.7K-5.40%1.63M--242.15K--1.72M
-Selling and marketing expense -82.22%48.67K499.89%483.53K24,856.06%273.77K1,046.72%80.6K--1.1K-59.86%7.03K--0--17.51K
-General and administrative expense 78.18%1.1M65.06%2.83M235.88%616.71K6.02%1.72M-24.18%183.61K-4.84%1.62M--242.15K--1.7M
Research and development costs 34.57%357.44K-64.16%342.17K3,210.74%265.63K-40.67%954.59K-561.03%-8.54K1,072.35%1.61M--1.85K--137.24K
Depreciation amortization depletion 30.91%1.33K1,678.33%4.27K--1.02K--240--0--0--------
-Depreciation and amortization 30.91%1.33K1,678.33%4.27K--1.02K--240--0--0--------
Other operating expenses --------------41.48M----------------
Operating profit -30.18%-1.51M91.72%-3.66M-556.84%-1.16M-1,267.39%-44.23M27.80%-176.17K-74.30%-3.23M-244K-1.86M
Net non-operating interest income expense 1,985.92%70.06K270.29%86.52K86.70%-3.72K-3,369.43%-50.81K-3,605.02%-27.94K1.55K797.02830
Non-operating interest income --72.82K4,388.61%95.79K--037.32%2.13K------1.55K------0
Non-operating interest expense -25.90%2.75K-82.49%9.27K-86.70%3.72K--52.94K--27.94K--0--------
Total other finance cost ---------------------------797.0283----
Other net income (expense) -47.56%682.99K166.74%4.59M1,333.47%1.3M-25,645.52%-6.87M-7,101.52%-105.58K1,276.42%26.91K-1.47K-2.29K
Gain on sale of security 475.84%682.99K269.97%525.1K-72.12%-181.73K-1,247.98%-308.95K-7,101.52%-105.58K1,276.42%26.91K---1.47K---2.29K
Special income (charges) ------0-------2.18M------0--------
-Less：Restructuring and merger&acquisition ------0------2.46M------0--------
-Less:Other special charges ---------------281.5K----------------
Other non- operating income (expenses) ----192.63%4.06M--1.48M---4.39M----------------
Income before tax -632.44%-753.25K101.98%1.01M145.68%141.47K-1,495.53%-51.16M-26.57%-309.68K-72.55%-3.21M-244.67K-1.86M
Income tax
Net income -632.44%-753.25K101.98%1.01M145.68%141.47K-1,495.53%-51.16M-26.57%-309.68K-72.55%-3.21M-244.67K-1.86M
Net income continuous Operations -632.44%-753.25K101.98%1.01M145.68%141.47K-1,495.53%-51.16M-26.57%-309.68K-72.55%-3.21M---244.67K---1.86M
Minority interest income
Net income attributable to the parent company -632.44%-753.25K101.98%1.01M145.68%141.47K-1,495.53%-51.16M-26.57%-309.68K-72.55%-3.21M-244.67K-1.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -632.44%-753.25K101.98%1.01M145.68%141.47K-1,495.53%-51.16M-26.57%-309.68K-72.55%-3.21M-244.67K-1.86M
Basic earnings per share -112.53%-0.51101.83%41.7628128.02%4.07-1,418.60%-2.28K-26.57%-14.5247-72.55%-150.3871-11.4754-87.1552
Diluted earnings per share -112.53%-0.51101.83%41.7628128.02%4.07-1,418.60%-2.28K-26.57%-14.5247-72.55%-150.3871-11.4754-87.1552
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--Unqualified Opinion with Explanatory Notes--------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -